Advanced search×

Molecular neuroendocrine targets for obesity therapy.

Annette D AD de Kloet and Stephen C SC Woods

Curr Opin Endocrinol Diabetes Obes 17(5):441-5 (2010) PMID 20585249

Although energy balance is tightly regulated in order to maintain a specific level of adiposity, the incidence of obesity continues to increase. Consequently, it is essential that effective therapeutics for the treatment and prevention of obesity be developed. This review provides a brief update on some recent advances in the characterization of neuroendocrine targets for obesity therapy.

DOI: 10.1097/MED.0b013e32833c3013
Version: za2963e q8za8 q8zb4 q8zc9 q8zd1 q8ze0 q8zf9 q8zg2

Similar articles you may find interesting…

  1. Associations between oral sensation, dietary behaviors and risk of cardiovascular disease (CVD)
    Valerie B VB Duffy

    Appetite 43(1):5 (2004) PMID 15262011

    We hypothesize that variation in oral sensation influences chronic disease risk by impacting dietary behaviors. Bitterness of 6-n-propylthiouracil (PROP) and fungiform papilla (FP) number serve as genetic taste markers. Data support that nontasters (who taste PROP as least bitter or have lowest FP n...
  2. Plasma levels of n-decanoyl ghrelin, another acyl- and active-form of ghrelin, in human subjects and the effect of glucose- or meal-ingestio...
    Junko Yoh, Yoshihiro Nishi, ... Jingo Kusukawa

    Regul Pept 167(1):9 (2011) PMID 21237214

    We examined the kinetics of D-ghrelin immunoreactivity in human plasma in comparison to O-ghrelin or total ghrelin by using a D-ghrelin-specific radioimmunoassay. The dynamics of plasma D-ghrelin was assessed following glucose- or meal-ingestion in healthy, non-obese subjects (5 males and 5 females)...